ITGB1 and breast cancer: Although both breast cancer cells in this study react differently to the ITGB1-kd with respect to DDR1, either by its upregulation (MDA-MB-231) or a slight downregulation (MCF-7), both cell lines confer COL1 binding into an active DDR1-mediated signaling via the MAPK pathway.